Cosmos Health Reports Record Revenue And Operating Metrics; Projects $12M Annualized U.S. NOOR Collagen Sales With 75% Gross Margins, Pursues U.S. Expansion And M&A Pipeline Including $11.5M Pharmacy Network Acquisition; Holds $18M In Non-Core Assets To Support Strategic Investments; Says Maintains Strong Growth Despite Geopolitical Turmoil; Plans To Issue Updated 2025 Operational, Strategic, And Financial Guidance Following Q4, FY25 Results - Cosmos Health (NASDAQ:COSM)
Despite the political turmoil, Cosmos Health reported record revenue and plans to expand its operations, including a potential $12m target for annualized revenue of about $30m.